{"id":"https://openalex.org/W4362420008","doi":"https://doi.org/10.1158/0008-5472.22399634","title":"Supplementary Figure 4 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment","display_name":"Supplementary Figure 4 from Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4362420008","doi":"https://doi.org/10.1158/0008-5472.22399634"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22399634","doi":"https://doi.org/10.1158/0008-5472.22399634","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22399634","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.22399634","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111698837","display_name":"Eveline M. Dijkgraaf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eveline M. Dijkgraaf","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084787739","display_name":"Moniek Heusinkveld","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moniek Heusinkveld","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053377794","display_name":"Bart Tummers","orcid":"https://orcid.org/0000-0001-7580-778X","observed_orcids":["https://orcid.org/0000-0001-7580-778X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bart Tummers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028443244","display_name":"Lisa T.C. Vogelpoel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa T.C. Vogelpoel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046560714","display_name":"Renske Goedemans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Renske Goedemans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102508187","display_name":"Veena Jha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veena Jha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111949100","display_name":"Johan W.R. Nortier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johan W.R. Nortier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069267169","display_name":"Marij J.P. Welters","orcid":"https://orcid.org/0000-0002-9809-8266","observed_orcids":["https://orcid.org/0000-0002-9809-8266"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marij J.P. Welters","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021122880","display_name":"Judith R. Kroep","orcid":"https://orcid.org/0000-0003-2671-1903","observed_orcids":["https://orcid.org/0000-0003-2671-1903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judith R. Kroep","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5041281028","display_name":"Sjoerd H. van der Burg","orcid":"https://orcid.org/0000-0002-6556-0354","observed_orcids":["https://orcid.org/0000-0002-6556-0354"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sjoerd H. van der Burg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.9089999794960022},{"id":"https://openalex.org/keywords/monocyte-differentiation","display_name":"monocyte differentiation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.9909999966621399},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tocilizumab","display_name":"tocilizumab","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/stat3-activation","display_name":"STAT3 activation","score":0.7170000076293945},{"id":"https://openalex.org/keywords/stat1","display_name":"STAT1","score":0.7870000004768372},{"id":"https://openalex.org/keywords/stat6","display_name":"STAT6","score":0.7599999904632568},{"id":"https://openalex.org/keywords/caov-3-cells","display_name":"CAOV3 cells","score":0.7940000295639038},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9039999842643738},{"id":"https://openalex.org/keywords/il-6-inhibition","display_name":"IL-6 inhibition","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7624817490577698},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5413264632225037},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5237227082252502},{"id":"https://openalex.org/C2777178219","wikidata":"https://www.wikidata.org/wiki/Q425154","display_name":"Tocilizumab","level":3,"score":0.4872197210788727},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.46005672216415405},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4161648750305176},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4023095667362213},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39466339349746704},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3778708577156067},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29393523931503296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2679944634437561},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21373099088668823},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1066979467868805},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22399634","doi":"https://doi.org/10.1158/0008-5472.22399634","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22399634","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22399634.v1","doi":"https://doi.org/10.1158/0008-5472.22399634.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22399634.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_Chemotherapy_Alters_Monocyte_Differentiation_to_Favor_Generation_of_Cancer-Supporting_M2_Macrophages_in_the_Tumor_Microenvironment/22399634/1/files/39845381.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22399634","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_4_from_Chemotherapy_Alters_Monocyte_Differentiation_to_Favor_Generation_of_Cancer-Supporting_M2_Macrophages_in_the_Tumor_Microenvironment/22399634","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22399634","doi":"https://doi.org/10.1158/0008-5472.22399634","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22399634","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362420008.pdf","grobid_xml":"https://content.openalex.org/works/W4362420008.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403260356","https://openalex.org/W4402567131","https://openalex.org/W3177466467","https://openalex.org/W1983470102","https://openalex.org/W2058118516","https://openalex.org/W4285586758","https://openalex.org/W1970666372","https://openalex.org/W7165014733","https://openalex.org/W2551612136","https://openalex.org/W6917396540"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"60K,":[3],"CAOV3":[4,33,38,54],"(an":[5],"ovarian":[6],"cancer":[7],"cell":[8],"line)":[9],"was":[10],"untreated,":[11],"cultured":[12],"with":[13,35,40,56,68],"tocilizumab":[14,36],"or":[15],"cisplatin.":[16,41],"After":[17],"24h,":[18],"intracellular":[19],"pSTAT-levels":[20],"were":[21],"measured":[22],"by":[23],"flow":[24],"cytometry.":[25],"A)":[26],"Example":[27],"of":[28,51],"staining":[29],"pSTAT3":[30,61],"for":[31],"CAOV3,":[32],"treated":[34,39,55],"and":[37,62,65],"B)":[42],"Geometric":[43],"mean":[44],"(background":[45],"subtracted":[46],"is":[47],"depicted.":[48],"Representative":[49],"experiment":[50],"three":[52],"experiments.":[53],"cisplatin":[57],"shows":[58],"an":[59],"increased":[60],"decreased":[63],"pSTAT1":[64],"6.":[66],"Treatment":[67],"Tocilizumab":[69],"reduced":[70],"STAT3":[71],"activation.":[72]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}